Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

NCT00139594 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
181
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis